Compare QTRX & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | BDSX |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 153.3M |
| IPO Year | 2017 | 2020 |
| Metric | QTRX | BDSX |
|---|---|---|
| Price | $3.87 | $21.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $6.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 1.1M | 94.5K |
| Earning Date | 05-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $37,632,000.00 | ★ $88,499,000.00 |
| Revenue This Year | $25.49 | $25.26 |
| Revenue Next Year | $10.04 | $19.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 64.52 | 24.08 |
| 52 Week Low | $2.40 | $0.29 |
| 52 Week High | $8.77 | $24.92 |
| Indicator | QTRX | BDSX |
|---|---|---|
| Relative Strength Index (RSI) | 54.38 | 60.37 |
| Support Level | $2.98 | $6.63 |
| Resistance Level | $4.57 | $24.92 |
| Average True Range (ATR) | 0.37 | 2.38 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 51.80 | 63.67 |
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.